373 related articles for article (PubMed ID: 33200774)
1. Interstitial Lung Disease and Myositis in a Patient With Antisynthetase Syndrome and PL12 and Ro52 Co-positivity in a Retired Medical Officer.
Loncharich MF; Anderson CW; Collins J; Edison J
Mil Med; 2021 Jul; 186(7-8):e836-e839. PubMed ID: 33200774
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience.
Zhang D; Wang H; Zhou X; Yang J; Liu Y; Wang W; Jiang P; Fan B
Immun Inflamm Dis; 2023 Nov; 11(11):e1085. PubMed ID: 38018600
[TBL] [Abstract][Full Text] [Related]
3. Outcome of anti-PL12 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Dominique S; Landron C; Roblot P; Jouneau S; Vittecoq O; Jouen F
Presse Med; 2013 Jun; 42(6 Pt 1):e153-8. PubMed ID: 23428662
[TBL] [Abstract][Full Text] [Related]
4. Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
Shi J; Li S; Yang H; Zhang Y; Peng Q; Lu X; Wang G
J Rheumatol; 2017 Jul; 44(7):1051-1057. PubMed ID: 28461650
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic Profiles Among 72 Caucasian and Afro-Caribbean Patients with Antisynthetase Syndrome Involving Anti-PL7 or Anti-PL12 Autoantibodies.
Abel A; Lazaro E; Ralazamahaleo M; Pierrisnard E; Suzon B; Bonnet F; Mercié P; Macey J; Agossou M; Viallard JF; Deligny C; Rivière E
Eur J Intern Med; 2023 Sep; 115():104-113. PubMed ID: 37330316
[TBL] [Abstract][Full Text] [Related]
6. Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody.
Sclafani A; D'Silva KM; Little BP; Miloslavsky EM; Locascio JJ; Sharma A; Montesi SB
Respir Res; 2019 Nov; 20(1):256. PubMed ID: 31718649
[TBL] [Abstract][Full Text] [Related]
7. Clinical characterisation of a multicentre nationwide cohort of patients with antisynthetase syndrome.
Martins P; Dourado E; Melo AT; Samões B; Sousa M; Freitas R; Lourenço MH; Fernandes B; Costa E; Parente H; Martins F; Fonseca JE; Cordeiro I; Romão VC; Khmelinskii N; Campanilho-Marques R
ARP Rheumatol; 2022 Nov; 1(ARP Rheumatology, nº3 2022):190-196. PubMed ID: 35891592
[TBL] [Abstract][Full Text] [Related]
8. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
Bauhammer J; Blank N; Max R; Lorenz HM; Wagner U; Krause D; Fiehn C
J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review.
Liu Y; Liu X; Xie M; Chen Z; He J; Wang Z; Dai J; Cai H
Respir Med; 2020; 165():105920. PubMed ID: 32174452
[TBL] [Abstract][Full Text] [Related]
10. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Dominique S; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Tiev KP; Vittecoq O; Noel D; Mouthon L; Menard JF; Jouen F
Autoimmun Rev; 2012 Aug; 11(10):739-45. PubMed ID: 22326685
[TBL] [Abstract][Full Text] [Related]
11. Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody.
Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF; Levesque H; Jouen F
Semin Arthritis Rheum; 2012 Jun; 41(6):890-9. PubMed ID: 22078416
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
[TBL] [Abstract][Full Text] [Related]
13. Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis.
Nayebirad S; Mohamadi A; Yousefi-Koma H; Javadi M; Farahmand K; Atef-Yekta R; Tamartash Z; Jameie M; Mohammadzadegan AM; Kavosi H
BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 38030264
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics of patients with antisynthetase syndrome and positive anti-Ro52 antibody].
Zhang X; Zhao XM; Yang QH; Lian CF; Li W; Yang L; Lu JM; Guan WJ; Zhang LJ; Cheng SH; Li H; Liu SY
Zhonghua Nei Ke Za Zhi; 2022 Feb; 61(2):200-204. PubMed ID: 35090256
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies.
Pinal-Fernandez I; Casal-Dominguez M; Huapaya JA; Albayda J; Paik JJ; Johnson C; Silhan L; Christopher-Stine L; Mammen AL; Danoff SK
Rheumatology (Oxford); 2017 Jun; 56(6):999-1007. PubMed ID: 28339994
[TBL] [Abstract][Full Text] [Related]
16. Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study.
Bozzalla-Cassione E; Zanframundo G; Biglia A; Bellis E; Bozzini S; Codullo V; Vertui V; Alpini C; Valentini A; Preda L; Montecucco C; Meloni F; Cavagna L
Clin Exp Rheumatol; 2022 May; 40 Suppl 134(5):27-31. PubMed ID: 35349417
[TBL] [Abstract][Full Text] [Related]
17. The differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies.
Valle A; Narain S; Barilla-Labarca ML; Marder G
Semin Arthritis Rheum; 2024 Apr; 65():152407. PubMed ID: 38377624
[TBL] [Abstract][Full Text] [Related]
18. A 64-year-old woman with interstitial lung disease and positive antibodies against aminoacyl-transfer RNA synthetases in the absence of myositis: presentation of an anti-PL-12 positive antisynthetase syndrome.
Ghysen K; Leys M
Acta Clin Belg; 2018 Oct; 73(5):389-392. PubMed ID: 29173135
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics of Anti-Synthetase Syndrome and Variables Associated with Interstitial Lung Disease and Mortality: A Retrospective Cohort Study.
Sodsri T; Petnak T; Ngamjanyaporn P
J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959314
[TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Hachulla E; Vittecoq O; Menard JF; Jouen F; Dominique S
Eur J Intern Med; 2013 Jul; 24(5):474-9. PubMed ID: 23375620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
